Insulin-like 3 (INSL3) is a hormone produced by fetal and adult Leydig cells of the testis and by theca and luteal cells of the adult ovary. In males, INSL3 regulates testicular descent during fetal life, whereas in adults, it acts as a germ cell survival factor. In the ovary, INSL3 regulates oocyte maturation. Despite its importance for male sex differentiation and reproductive function in both sexes, very little is known regarding the molecular mechanisms that regulate Insl3 expression. So far, the nuclear receptor NR5A1 is the only transcription factor known to regulate the mouse Insl3 promoter in Leydig cells. NR5A1 by itself, however, cannot explain the spatiotemporal expression pattern of the Insl3 gene. In the present study, we have identified the orphan nuclear receptor NR4A1 as a novel regulator of INSL3 transcription in Leydig cells. Using RT-PCR, we found that Nr4a1 is coexpressed with Insl3 in purified Leydig cells and in several Leydig cell lines. Through detailed analyses of the mouse and human INSL3 promoter in Leydig cells, we have mapped a novel regulatory element located at À100 bp that is essential and sufficient to confer NR4A1 responsiveness. Consistent with a role for NR4A1 in Insl3 transcription, chromatin immunoprecipitation assays revealed that endogenous NR4A1 binds to the proximal Insl3 promoter in vivo. Finally, we found that NR4A1 is also implicated in cAMP-induced Insl3 transcription in Leydig cells. Taken together, our identification of NR4A1 as an important regulator of mouse and human INSL3 promoter activity helps us to better define the tissue-specific regulation of the INSL3 gene in gonadal cells.
INTRODUCTION
Insulin-like 3 (INSL3) or relaxin-like factor (RLF) belongs to the insulin-IGF-relaxin family of growth factors and hormones and is specifically expressed in testicular Leydig cells and in the ovary [1, 2] . In fetal Leydig cells, Insl3 is strongly expressed from Embryonic Day 13.5 (e13.5) in mice [3] and its expression decreases after birth, with the disappearance of the fetal Leydig cell population [3, 4] . Insl3 expression in the adult population of Leydig cells rises just prior to puberty, peaks in adults animals, and then declines in aging animals [2] [3] [4] [5] [6] . The second wave of Insl3 expression depends on a functional hypothalamo-pituitary-gonadal (HPG) axis as revealed by the lack of Insl3 expression in hpg mice [4] that have a deletion of the Gnrh1 gene and thus a nonfunctional HPG axis [7, 8] . Interestingly, Insl3 expression could be restored by administration of hCG to hpg mice [4] . Another study also confirmed that Insl3 expression in the gonads is upregulated in vivo by LH [9] . Insl3 expression, however, is not limited to testicular Leydig cells; it is also found in follicular theca cells and luteal cells of the adult ovary, albeit at a much lower level than in testicular Leydig cells [3, 4] .
In males, INSL3 plays two distinct roles. First, during fetal life, INSL3 controls the initial phase of testicular descent, which constitutes a normal and obligatory step of the male sex differentiation process [10, 11] . Definitive proof that INSL3 was indeed responsible for the first phase of testicular descent came from gene inactivation experiments in the mouse. Two knockout alleles of the Insl3 gene, Insl3 tm1Imad /Insl3 tm1Imad and Insl3 tm1Par /Insl3 tm1Par , were generated by two independent laboratories [12, 13] . Insl3 À/À mice had bilateral cryptorchid testes located high in the abdominal cavity close to the kidneys [12, 13] . Further support for INSL3 as a regulator of testicular descent came from elegant transgenic experiments where INSL3 was overexpressed in pancreatic b cells of Insl3 À/À mice [14] . In these animals, normal testis descent was restored. Even more convincing was the generation of female transgenic mice (TG(Ins2-Insl3)4Imad) overexpressing INSL3, which led to descended ovaries [14, 15] . The second role of INSL3 is in adult males, where it was recently shown to act as a germ cell survival factor [9] . In females, INSL3 plays a role in oocyte maturation [9] .
Because INSL3 plays critical roles in male sex differentiation and in reproductive function of both sexes, understanding the mechanisms that regulate its expression is of paramount importance. Although the INSL3 promoter has been isolated from several species [3, [16] [17] [18] , very little is known about its transcriptional regulation. So far, three consensus binding sites for nuclear receptors have been identified in the rodent proximal Insl3 promoter, suggesting a role for members of this family of transcription factors in the regulation of Insl3 expression. Consistent with this, two groups have reported that the nuclear receptor NR5A1, also known as SF-1 and Ad4BP, can bind to and activate the mouse Insl3 promoter [19, 20] . Other evidence, however, indicates that NR5A1 is, to a certain extent, dispensable for Insl3 transcription in vivo. For instance, there was a partial descent of the testes to the level of the bladder in Leydig cell-specific Nr5a1-null mice, suggesting that these animals retain some capacity to produce INSL3 [21] . Moreover, of the three NR5A1 binding sites found in the rodent Insl3 promoter, only one is conserved in the human and pig INSL3 promoter. Finally, Nr5a1 expression in the testis remains high throughout life (reviewed in [22] ), whereas Insl3 expression declines after birth and increases prior to puberty [2] [3] [4] . Therefore, other transcription factors are required for the initiation and maintenance of Insl3 transcription.
NR4A1 (Nur77, NGFI-B, TR3) is the founding member of the NR4A family of orphan nuclear receptors, which also includes NR4A2 (Nurr1) and NR4A3 (Nor1). These transcription factors are known to be immediate-early response factors in several tissues, including steroidogenic gonadal cells [23, 24] . In these cells, NR4A1 is present at low levels and is strongly induced in response to LH and cAMP analogs [23, 24] . In recent years, members of the NR4A family, particularly NR4A1 and NR4A2, have received increased attention as novel regulators of basal and hormone-induced gene transcription in testicular Leydig cells. Interestingly, NR4A1 is known to bind as monomer to a regulatory element similar to that recognized by NR5A1, suggesting that these two nuclear receptors might regulate a common set of genes [25] . Indeed, NR4A1 stimulates the promoters of several genes involved in testosterone biosynthesis in Leydig cells that are also known to be activated by SF-1. These include the human HSD3B2, rat Cyp17a1, mouse Hsd3b1, and mouse Star promoters [23, 26, 27] .
We now report that the mouse and human INSL3 promoter is a novel target for the orphan nuclear receptor NR4A1 (Nur77/NGFI-B) in testicular Leydig cells. Using detailed promoter analyses, we have identified a novel NR4A1 response element (NBRE) located at À100 bp that is recognized by NR4A1. This species-conserved NBRE element is also essential and sufficient to confer NR4A1 and cAMP responsiveness to the mouse and human INSL3 promoter. Thus, our results provide important new insights into the mechanisms of INSL3 gene transcription in testicular Leydig cells.
MATERIALS AND METHODS

Plasmids
The À1137-bp to þ11-bp human INSL3 promoter (hINSL3) fragment was isolated by PCR using human genomic DNA as template and the following primers: forward: 5 0 -CTA GGA TCC TGC CAT TAC AGG CCA AC-3 0 (BamHI cloning site is underlined); reverse: 5 0 -GG GGT ACC GGT GGG TGG CGC CGG GGC CAA GC-3 0 (KpnI cloning site is underlined). Deletions of the hINSL3 promoter to À920 bp, À656 bp, À322 bp, and À93 bp were obtained by PCR using the À1137-bp hINSL3 promoter as template, along with the same reverse primer described above and the following forward primers (BamHI cloning site is underlined): À920 bp, 5 0 -CG GGA TCC TGT AGT CCC AGC TAC TCA GG-3 0 ; À656 bp, 5 0 -CG GGA TCC AGC CTG GAA GAC AGA GCA AG-3 0 ; À322 bp, 5 0 -CG GGA TCC AGG CTG AGG CAG GAG AAT CGC-3 0 ; À93 bp, 5 0 -CG GGA TCC TGG GCG GTC CTG AAG AAT G-3 0 . The À1137-bp reporter containing a mutation of the NBRE element at À100 was obtained by site-directed mutagenesis using the QuickChange XL mutagenesis kit (Stratagene, La Jolla, CA) and the following pair of oligos (the mutations are in bold and underlined): sense: 5 0 -CTG GCA CTA ACC CCA CCC TGA TTT TTT TCC TGG GCG GTC CTG-3 0 , antisense: 5 0 -CAG GAC CGC CCA GGA AAA AAA TCA GGG TGG GGT TAG TGC CAG-3 0 . The À189-bp mouse Insl3 (mInsl3) promoter fragment was isolated by PCR using mouse genomic DNA and the following primers: forward: 5 0 -CG GGA TCC AAT GTT GGG GAG CGG CTC CTG-3' (BamHI cloning site is underlined), reverse: 5 0 -GG GGT ACC GTG GCA GGA GGC AGT GGG CAG-3' (KpnI cloning site is underlined). All promoter fragments were cloned into a modified pXP1 luciferase reporter plasmid [28, 29] , and subsequently verified by sequencing. A pcDNA3-based expression vector for the truncated NR4A1 protein (aa 252-601) was constructed by PCR using the following primers: forward, 5 0 -ATG GTG ACC TCC ACC AAG TCC CGG-3 0 and reverse, 5 0 -TCA GAA AGA CAA GGT GTC CAT-3 0 . The mouse NR5A1 expression vector has been previously described [29] . Expression vectors for full-length NR4A1, NR4A2, and NR4A3 [30] were kindly provided by Dr. Jacques Drouin (Laboratoire de Génétique Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Canada). The human NR5A2 expression vector [31] was provided by Dr. Luc Bélanger (Centre de recherche en cancérologie, Centre de recherche du CHUQ, Université Laval, Québec, Canada).
Cell Culture and Transfections
The mouse Sertoli cell lines 15P-1 [32] and TM4 [33] and Leydig cell line TM3 [33] were obtained from American Type Culture Collection. The mouse Sertoli cell line MSC-1 [34] was obtained from Dr. Michael Griswold (Washington State University, Pullman, WA). The mouse Leydig cell line MA-10 [35] was provided by Dr. Mario Ascoli (University of Iowa, Iowa City, IA). The 15P-1, TM3, TM4, and MSC-1 cell lines were grown in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum. MA-10 Leydig cells were grown and transfected as previously described [23] . When indicated, MA-10 cells were treated with 0.5 mM (Bu) 2 cAMP 4 h prior to harvesting. Data reported represent the average of at least three experiments, each done in duplicate.
Electromobility Shift Assays
Recombinant NR4A1, NR4A2, NR4A3, NR5A1, and NR5A2 proteins were in vitro translated using the T 7 QuickCoupled TnT system (Promega, Madison, WI). Nuclear extracts were obtained from MA-10 cells treated with 0.5 mM (Bu) 2 cAMP for 4 h. DNA binding assays were performed using either 10 lg of nuclear extracts or 1-2 ll of in vitro-translated protein as described in [23] . The 
RNA Isolation and RT-PCR
Total RNAs from purified Leydig cells isolated from rats at different developmental stages (progenitor Leydig cells, PLC; immature Leydig cells, ILC; mature Leydig cells, MLC) were kindly provided by Dr. Matthew Hardy (The Population Council, Rockefeller University, New York, NY). Total RNA was prepared from adult testes of CD-1 mice and the Leydig cell lines MA-10 and TM3 by the single-step acid guanidinium thiocyanate-phenol-chloroform method [36] . Different first-strand cDNAs were synthesized from a 5-lg aliquot of the various RNAs using the Superscript II Reverse Transcriptase System (Invitrogen Canada, Burlington, ON). One twentieth of the first-strand cDNA preparations (one 50th for Tubulin) were used as templates in the PCR reactions using VENT DNA polymerase (New England Biolabs, Mississauga, ON) and oligonucleotide primers specific for Insl3 (forward primer: 5 0 -CAT GCG CGC GCC GCT GCT AC-3 0 , reverse primer: 5 0 -TCA GTG GGG ACA CAG ACC C-3 0 ), Nr4a1 (forward primer: 5 0 -GCC AAG TAC ATC TGC CTG GC-3 0 , reverse primer: 5 0 -CCA GGC CTG AGC AGA AGA TGA GC-3 0 ), Nr5a1 (forward primer: 5 0 -CCG GAA CAA GTT TGG GCC CAT GT-3 0 , reverse primer: 5 0 -CAG ACG AAC TCC TGG CGG TCC AG-3 0 ), and Tubulin (forward primer: 5 0 -TCC ATC CAC GTC GGC CAG GCT-3 0 , reverse primer: 5 0 -GTA GGG CTC AAC CAC AGC AGT-3 0 ). The various PCRs were done simultaneously on a T gradient thermocycler (Biometra) using the following conditions: 3 min at 948C followed by 28 cycles of denaturation (50 sec at 948C), annealing (1 min at various temperatures; see below), extension (1 min at 728C), and a final extension of 5 min at 728C. The annealing temperatures were 658C for Insl3, 588C for NR4A1, 628C for NR5A1, and 608C for Tubulin. The PCR products were subcloned in pBluescript (Stratagene) and sequenced on a ABI 3730/XL automated sequencer (Centre de génomique de Québec, Québec City, Canada) to confirm the nature of the amplified cDNAs.
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Real-Time PCR
Real-time PCR was used to quantify Insl3 mRNA levels. The Insl3-specific primers are the same as those described above. A standard curve was first established using serial dilutions (500 pg to 5 fg) of a plasmid containing the Insl3 cDNA. The real-time PCRs were carried out using a LightCycler 1.5 instrument from Roche Diagnostics, Laval, Canada. Reactions were performed according to the manufacturer's recommendations using either 5 ng of cDNAs or plasmid standard. As an internal control, the 18S rRNA was amplified using the following primers: forward, 5 0 -GTA ACC CGT TGA ACC CCA TT-3 0 and reverse, 5 0 -CCA TCC AAT CGG TAG TAG CG-3 0 . The PCRs were performed using the following conditions: 10 min at 958C followed by 35 cycles of denaturation (5 sec at 958C), annealing (5 sec at 588C for 18S rRNA and at 648C for Insl3 mRNA), and extension (20 sec at 728C) with single acquisition of fluorescence at the end of the extension step. After amplification, the samples were slowly heated at 0.28C/sec from 75 to 958C with continuous reading of fluorescence to obtain a melting curve. The specificity of each PCR product was then determined by using the melting-curve analysis program of the LightCycler software and confirmed by agarose gel electrophoresis. The Insl3 and 18S PCR products showed a single peak in the analysis. Quantitative analyses of the data were performed using the LightCycler analysis software package (Roche Diagnostics). Second-derivative maximum analysis, arithmetic base line adjustment, and polynomial calculation were used. Quantification of mRNA levels was calculated by reference to the respective standard curve. Relative gene expression was expressed as a ratio of Insl3 mRNA levels to 18S rRNA levels. Each amplification was performed in triplicate using at least two different preparations of first-strand cDNAs.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assays were performed according the technique described by Spencer et al. [37] , with some modifications. Briefly, MA-10 cells were plated at 1.5 3 10 6 cells in 60-mm dishes. Fortyeight hours after plating, proteins were cross-linked to DNA by adding 1% formaldehyde directly to the media and incubating for 10 min at 378C. Cells were washed twice with ice-cold PBS containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 lg/ml aprotinin, 1 lg/ml leupeptin, and 1 lg/ ml pepstatin A). Cells were collected, pelleted, and resuspended in 200 ll of SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH 8.0) containing appropriate protease inhibitors. Sonication was performed on ice using a BraunSonic 1510 Sonicator for 4 cycles of 15-sec pulses at six output control and 40% duty cycle in order to obtain DNA fragments between 200 bp and 1000 bp in size. Sheared chromatin was then diluted 10-fold in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.0, 167 mM NaCl) containing appropriate protease inhibitors. A 1% aliquot was kept to quantitate the amount of DNA present in different samples before immunoprecipitation (input). Cross-linked DNA was immunoprecipitated with anti-NR4A1 (M-210, Santa Cruz Biotechnology) overnight with rotation at 48C. Immunocomplexes were collected using a salmon sperm/protein G sepharose slurry and subsequently washed one time each with low salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 150 mM NaCl), high salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl), LiCl buffer (0.25 M LiCl, 1% IGEPAL, 1% SDS, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0) and twice with Tris-EDTA buffer (20 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0). Protein-DNA complexes were eluted from protein G sepharose beads by addition of elution buffer (1% SDS, 0.1 M NaHCO 3 ) and rotation at room temperature. Cross-links were reversed by addition of 200 mM of NaCl and heating at 658C for 4 h. Proteins were degraded using proteinase K treatment (1 h at 558C) and the DNA fragments were purified by phenol/chloroform extraction and EtOH precipitation. PCRs were done using 0.5 ll of input chromatin sample and 5 ll of NR4A1-immunoprecipitated DNA sample with primers specific for the proximal region (À189 to þ5 bp) of the mouse INSL3 promoter (forward: 5 0 -AAT GTT GGG GAG CGG CTC CTG-3 0 ; reverse: 5 0 -GTG GCA GGA GGC AGT GGG CAG-3 0 ). PCRs were carried out using Vent polymerase (New England Biolabs) at 948C for 5 min, followed by 40 cycles of 948C for 1 min, 628C for 1 min, and 728C for 30 sec, and completed by a final extension of 5 min at 728C. The PCR products were analyzed by electrophoresis on a 2% ethidium bromide-stained agarose gel. ChIP results were confirmed by at least three separate experiments.
Statistical Analyses
Statistical analyses were done using the Kruskal-Wallis one-way analysis of variance followed by Mann-Whitney U-test to identify significant differences (for Figs. 2 and 8 ). For Figures 3, 4 , and 7, individual comparisons were done using the Mann-Whitney U-test. For all statistical analyses, P , 0.05 was considered significant.
RESULTS
Coexpression of NR4A1 and INSL3 in Leydig Cell Lines
NR4A1 is an orphan nuclear receptor expressed in Leydig cells [23, 24] . As a first step to assess the role of NR4A1 in Insl3 expression, we used RT-PCR to compare expression of Nr4a1, Nr5a1, and Insl3 in adult mouse testes, two Leydig cell lines (MA-10 and TM3), purified rat Leydig cells at different postnatal developmental stages (progenitor, immature, and mature Leydig cells), and three Sertoli cell lines (15P-1, MSC-1, TM4). As shown in Figure 1 , we found that Nr4a1 is coexpressed with Insl3 in both Leydig cell lines as well as in purified Leydig cells at all developmental stages.
Activation of Mouse and Human INSL3 Promoter by NR4A1
The fact that Nr4a1 is coexpressed with Insl3 in Leydig cells suggests that this transcription factor could be involved in Insl3 transcription in these cells. To test this hypothesis, we isolated a fragment of the mouse and human INSL3 promoter and performed transient transfection assays in MA-10 Leydig cells. As shown in Figure 2 , A and B, NR4A1, as well as the other NR4A family members NR4A2 and NR4A3, could activate a À1137-bp human INSL3 (hINSL3) reporter construct (3-to 4-fold), whereas NR5A1 and NR5A2 were weaker activators (1.8-and 1.6-fold, respectively). Similar results were obtained with the mouse Insl3 promoter (Fig. 2C) .
Localization of the NR4A1-Responsive Element
To locate the NR4A1-responsive element, 5 0 -progressive deletions of the hINSL3 promoter were generated and tested for NR4A1 responsiveness in MA-10 cells (Fig. 3) . A deletion construct to À322 bp was still activated by NR4A1. However, further deletion to À93 bp, that retains the NR5A1 element at À56 bp, completely abrogated transactivation of the hINSL3 . First-strand cDNAs were prepared as described in Materials and Methods. Omission of cDNAs was used as negative control (water). Amplification of Tubulin was performed to validate the quantity and integrity of the cDNAs. Shown is a representative experiment of at least three separate amplifications using different firststrand cDNA preparations.
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promoter by NR4A1 (Fig. 3) . Taken together, these results indicated that the NR5A1 element is not required for NR4A1-dependent activation of the hINSL3 promoter and that a novel, yet unidentified, element located between À322 and À93 bp is responsible for NR4A1 responsiveness. Indeed, sequence analysis of this promoter region revealed the presence of a consensus NR4A1 NBRE located at position À100 bp that is conserved across species (Fig. 4A) . The importance of this novel NBRE was next assessed by site-directed mutagenesis. As shown in Figure 4B , mutation of the À100-bp NBRE (AAAGGTCA ! AAATTTCA) completely abolished NR4A1-dependent activation of the human (left panel) and mouse (right panel) INSL3 promoter. Mutation of the NBRE also led to a loss of ;20% in the basal activity of the human INSL3 promoter (Fig. 4C, left panel) , whereas basal activity of the mouse Insl3 promoter was reduced by ;80% (Fig. 4C,  right panel) . The more dramatic effect seen on the mouse promoter could be due to the fact that MA-10 Leydig cells are of mouse origin and they would therefore correspond to a more natural and favorable environment for the mouse Insl3 promoter. Altogether, these results indicate that the NBRE at À100 bp is required for maximal INSL3-promoter activity in Leydig cells and that it is both necessary and sufficient to confer NR4A1-responsiveness to the mouse and human INSL3 promoter.
Specific Binding of NR4A1 to the NBRE (À100 bp)
DNA binding of NR4A1 to the novel NBRE (À100 bp) was first assessed by electromobility shift assays (EMSA). Consistent with the requirement for the NBRE in NR4A1-mediated activation of the mouse and human INSL3 promoter (Fig. 4B) , in vitro translated NR4A family members (NR4A1, NR4A2, and NR4A3) bound to the NBRE (Fig. 5A, left panel) . NR5A family members could also bind to this NBRE, although their binding appears weaker (Fig. 5A, right panel) . Next, the DNA-binding specificity of NR4A1 was analyzed by competition experiments. As shown in Figure 5B , NR4A1 binding was specifically competed by increasing doses of unlabeled oligonucleotides (Fig. 5B, lanes 3 and 4) as well as by unlabeled oligonucleotides corresponding to the NBRE that we have recently identified in the human HSD3B2 promoter (Fig.   FIG. 2 
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325 5B, lanes 7 and 8). NR4A1 binding, however, was not displaced by oligonucleotides harboring a mutation in the hINSL3 or the hHSD3B2 NBREs (Fig. 5B, lanes 5, 6, 9 , and 10), known to abolish NR4A1-dependent activation (Fig. 4B  and [23] ).
NR4A1 DNA-binding activity was also tested by EMSA using nuclear extracts from MA-10 Leydig cells and the NBRE from the human (Fig. 6A, left panel) and mouse (Fig. 6A, right  panel) INSL3 promoter. In both cases, a band (Fig. 6A , lanes 2 and 5) was detected. This band was mostly supershifted by the addition of an anti-NR4A1 antiserum (Fig. 6A, lanes 3 and 6) . The remaining DNA-binding activity could be due to NR4A2, NR5A1, or NR5A2, which can bind to this element (Fig. 5A ) but are not recognized by the anti-NR4A1 antiserum. Thus, endogenous NR4A1 can bind to the novel NBRE in the mouse and human INSL3 promoter.
Next, ChIP assays were performed to detect in vivo binding of NR4A1 to the mouse Insl3 promoter in MA-10 cells. Proteins were cross-linked to the chromatin, which was then sheared and subjected to immunoprecipitation using an anti- P-labeled oligonucleotide corresponding to the NBRE at À100 bp of the hINSL3 promoter. The inset at the bottom of the right panel corresponds to an SDS-PAGE of the in vitro-produced proteins to validate the levels of the proteins. B) Competition experiments were used to assess the DNA-binding specificity of NR4A1 to a double-stranded 32 P-labeled oligonucleotide corresponding to the NBRE at À100 bp. Binding of NR4A1 was challenged by increasing doses (black triangles; molar excesses of 23 and 53) of unlabeled oligonucleotides corresponding to the wild-type À100-bp NBRE from the hINSL3 promoter (INSL3 wt), the À100-bp NBRE mutated from AAAGGTCA to AAATTTCA (INSL3 mut), the wild-type À130-bp NBRE from the human HSD3B2 promoter (HSD3B2 wt), and the À130-bp element containing a mutation (HSD3B2 mut) in the NBRE element (TAAAGGTCA ! TAAATTTCA).
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ROBERT ET AL. NR4A1 antiserum (aNR4A1). By PCR, a band of ;200 bp was detected in the input sample (Fig. 6B, lane 3) as well as in the two samples immunoprecipitated with the anti-NR4A1 antiserum (Fig. 6B, lanes 4 and 5) but not from the control sample (Fig. 6B, lane 1) . This band migrates at the same position as a band obtained with a plasmid containing the mouse Insl3 promoter (Fig. 6B, lane 2) . NR4A1 is thus bound on the Insl3 promoter in vivo in MA-10 Leydig cells.
The NBRE is Required for the cAMP-Mediated INSL3 Promoter Activation
The fact that Nr4a1 and Insl3 are both upregulated in response to LH/hCG in vivo raises the possibility that NR4A1 might be involved in this upregulation of Insl3. We first tested whether cAMP treatment of MA-10 Leydig cells could stimulate Insl3 expression. Using real-time PCR, we found that Insl3 mRNA levels were increased ;2.2-fold following a 4-h treatment with 0.5 mM (Bu) 2 cAMP (Fig. 7A ). Next, we tested whether cAMP could activate the mouse and human INSL3 promoter activity and if this required the NBRE at À100 bp. As shown in Figure 7B , a 2.5-fold cAMP-dependent activation of the human (left panel) and mouse (right panel) INSL3 promoter was observed (hatched bars). This stimulation was lost when the NBRE was mutated, suggesting that NR4A1, which binds to this element (Figs. 5 and 6) , might act as a mediator of cAMP in the regulation of the mouse and human INSL3 promoter activity.
To assess whether endogenous NR4A family members are involved in the cAMP-induced Insl3 promoter activity, we generated a truncated NR4A1 protein (aa 252-601). Because this protein lacks its N-terminal activation domain but retains the DNA-binding domain, it could therefore bind to DNA but could no longer activate the mouse and human INSL3 promoter (CTL bars in the left panels of Fig. 8, A and B) . In addition, the NR4A1 truncated protein could antagonize in a dose-dependent manner the activation of the mouse and human INSL3 mediated by the wild-type NR4A1 protein (NR4A1 bars in the left panels of Fig. 8, A and B) . Thus, the truncated NR4A1 protein behaves as a dominant negative competitor. When overexpressed in MA-10 Leydig cells, the NR4A1 dominant negative protein decreased cAMP-induced activity of the mouse and human INSL3 promoter (cAMP bars in the left panels of Fig. 8,  A and B) . These effects were specific and mediated through the NBRE because reporters harboring a mutation of this element were unaffected by the NR4A1 dominant negative protein 
NR4A1 REGULATES INSL3 PROMOTER ACTIVITY
(right panels of Fig. 8, A and B) . Altogether, these results indicate that endogenous NR4A proteins are involved in the cAMP stimulation of the INSL3 promoter.
DISCUSSION
Although the physiological roles of INSL3 in mammalian reproductive function are well established, very little is known regarding the molecular mechanisms that regulate its expression in gonadal cells. So far, NR5A1 is the only transcription factor known to regulate mouse Insl3 promoter activity; it alone, however, cannot explain the highly specific and dynamic Insl3 expression pattern. Due to its similarities with Insl3 in terms of expression pattern and hormonal regulation, the NR4A1 transcription factor is an interesting candidate regulator of the Insl3 gene. During gonadal development, Nr4a1 is 3-4 times more abundantly expressed in the fetal testis than in the fetal ovary [38] . Just prior to puberty and upon activation of the HPG axis, Nr4a1 expression levels are upregulated in the testis [24] . Nr4a1 expression is also known to be increased in response to LH/hCG/cAMP in Leydig cells as well as in the ovary [23, 24, 39] . Taken together, these observations argue in favor of a role for NR4A1 in Insl3 transcription. In agreement with this, we have now identified the mouse and human INSL3 promoter as a target for NR4A1 in Leydig cells.
Although NR4A1 and NR5A1 are nuclear receptors that bind as monomers to similar DNA regulatory sequences, they nonetheless have specific requirements for the 5 0 nucleotides of their binding site. Indeed, NR4A1 strongly binds to the sequence (T/A)AA AGGTCA, whereas NR5A1 prefers (C/ T)CA AGGTCA [25, 40] . Thus, NR4A1 can only weakly bind to the NR5A1 element and NR5A1 poorly recognizes the NBRE [25, 40] . Our in vitro EMSA data are consistent with this because we found that, although NR4A and NR5A family members can all bind to the novel NBRE (AAA AGGTCA) that we have identified in the mouse and human INSL3 promoter, binding of NR4A family members was stronger than that of NR5A family members (Fig. 5A ). In agreement with this, we also found that NR4A1 and NR5A1 regulate INSL3 promoter activity via their respective binding sites. This is supported by the fact that NR4A1-dependent activation of the mouse and human INSL3 promoter was lost when the NBRE at À100 bp was either deleted or mutated despite the presence of an intact NR5A1 element at À56 bp (Figs. 3 and 4B) . Similarly, mutation of the NBRE did not impair the activation of the INSL3 promoter by NR5A1 (data not shown). Moreover, we found no transcriptional cooperation between these two transcription factors (data not shown). It is well known, however, that ubiquitously expressed and/or cell-specific transcription factors interact to form a unique combinatorial code to direct proper tissue-, cell-, and promoter-specific transcription. Thus, it is highly probable that other transcription factors are involved in regulating INSL3 expression. Supporting this is the fact that Sertoli cell lines do express Nr4a1 and Nr5a1 but do not express Insl3 (Fig. 1) . Furthermore, we have found that the proximal mouse and human INSL3 promoter contains other species-conserved regulatory elements besides the NBRE and NR5A1 motifs (unpublished observations). The transcription factors binding to these elements, however, remain to be identified.
The lack of an overt reproductive phenotype in Nr4a1 tm1Jmi / Nr4a1 tm1Jmi mice, in which the Nr4a1 gene has been deleted by homologous recombination [41] , would appear to argue against a role for NR4A1 in Insl3 transcription. A possible explanation is that other NR4A nuclear receptors can compensate for the absence of NR4A1. Indeed, Nr4a2 was shown to be upregulated in Nr4a1 À/À mice [41] . Moreover, NR4A1 and NR4A3 have been shown to be functionally redundant in vivo in thymocyte gene expression [42] . Thus, there is strong evidence that the various NR4A family members can indeed compensate for one another in vivo. This likely includes the mammalian gonads, where two other NR4A family members, NR4A2 and NR4A3, are coexpressed with NR4A1 [24, 43, 44] . In support of this, we showed that NR4A2 and NR4A3 can activate the INSL3 promoter as well as NR4A1 (Fig. 2B) .
Because LH action is required for proper Insl3 expression in postnatal Leydig cells [4] , NR4A1 might be one of the downstream effectors of LH in the regulation of Insl3 expression. LH is known to mediate its effects on Leydig cell differentiation and function by binding to its G-protein-coupled receptor leading to activation of the cAMP/PKA pathway (reviewed in [45] ). The downstream effectors of LH signaling in Leydig cells, however, remain poorly characterized. We and others have shown that Nr4a1 expression is robustly induced both at the mRNA and protein levels in response to LH/hCG/ cAMP in Leydig cells in vitro and in vivo [23, 24] . Consistent with the fact that Insl3 expression is regulated by the chronic effects of LH (in contrast with its acute effects on steroidogenesis) [4, 46] , NR4A1 levels remain high for more than 12 h following hCG treatment [24] . Our current data support a role for NR4A family members in the cAMP-induced Insl3 transcription in Leydig cells. Indeed, mutation of the NBRE in the mouse and human INSL3 promoter, which 328 prevents binding and activation by NR4A1 (Figs. 4B and 5) , abolished cAMP responsiveness of the promoter (Fig. 7B) . Furthermore, we used a truncated NR4A1 protein that acts as a dominant negative competitor to confirm the functional implication of NR4A family members endogenously expressed in MA-10 Leydig cells in the cAMP-mediated increase in mouse and human INSL3 promoter activity. We found that overexpression of this dominant negative NR4A1 protein in MA-10 cells significantly blunted the response to cAMP (Fig.  8) .
The identification of NR4A1 as a regulator of Insl3 expression might also help us better understand the mechanisms of action of certain endocrine-disrupting chemicals that have deleterious effects on the male reproductive system. Indeed, the Insl3 gene is a known target for certain classes of endocrine-disrupting chemicals, particularly phthalates and estrogenic compounds, all of which have been associated with cryptorchidism (undescended testis) in humans and rodents [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] . Using mice models, it was shown that Insl3 expression levels in male embryos were severely reduced following in utero exposure to estrogens and phthalates [53, 59, 60] . In both cases, insufficient INSL3 levels were associated with failure of testicular descent. These studies also revealed that Nr5a1 expression in fetal Leydig cells was not affected by maternal exposure to estrogens or phthalates [59, 61] . Thus, it is likely that repression of Insl3 by estrogens and phthalates involves additional transcription factors. NR4A1 might represent such a factor.
